Home
>
National Drug Code (NDC)
>
Tekamlo
Tekamlo - 0078-0603-34 - (Aliskiren Hemifumarate and Amlodipine Besylate)
Drug Information of Tekamlo
| Product NDC: | 0078-0603 |
| Proprietary Name: | Tekamlo |
| Non Proprietary Name: | Aliskiren Hemifumarate and Amlodipine Besylate |
| Active Ingredient(s): | 150; 5 mg/1; mg/1 & nbsp; Aliskiren Hemifumarate and Amlodipine Besylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tekamlo
| Product NDC: | 0078-0603 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022545 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100101 |
Package Information of Tekamlo
| Package NDC: | 0078-0603-34 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0603-34) |
NDC Information of Tekamlo
| NDC Code | 0078-0603-34 |
| Proprietary Name | Tekamlo |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0603-34) |
| Product NDC | 0078-0603 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Aliskiren Hemifumarate and Amlodipine Besylate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100101 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE |
| Strength Number | 150; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Renin Inhibitor [EPC],Renin Inhibitors [MoA],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
